Cerus Corp (CERS) 6.09 $CERS Showpad Helps Cerus

New Post Public Reply Private Reply Replies (0) Message Board

Jun 11, 2016 at 11:18 PM

Cerus Corp (CERS) 6.09 $CERS

Showpad Helps Cerus Corporation Share Vital Information During Zika Epidemic
PR Newswire Europe - Wed Jun 01, 1:30AM CDT
Showpad, the leading sales enablement platform that guides reps to results, today announced that its customer Cerus Corporation, a biomedical company focused in the field of blood transfusion safety, is using Showpad to help educate its blood center customers about ways to maintain the safety of the blood supply during a Zika epidemic. Cerus is able to leverage the Showpad platform quickly and efficiently to share vital medical information with its field sales organization.
CERS: 6.09 (+0.12)

How Well are These Healthcare Stocks Performing? - Radius Health, Cerus, Arrowhead Pharma, and Five Prime Therapeutics
PR Newswire - Thu May 26, 7:50AM CDT
Despite the volatility that continues to envelop the Biotech industry, investors see value in this space. Today's pre-market research on ActiveWallSt.com directs the investor community's focus on the following Healthcare equities: Radius Health Inc. (NASDAQ: RDUS), Cerus Corp. (NASDAQ: CERS), Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR), and Five Prime Therapeutics Inc. (NASDAQ: FPRX). Register with us today for these stock technical briefings at:
CERS: 6.09 (+0.12), RDUS: 36.64 (-0.05), ARWR: 5.85 (-0.14), FPRX: 42.87 (+0.69)

Health Canada Approves INTERCEPT Blood System for Plasma
BusinessWire - Mon May 23, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) today announced that Health Canada has approved the INTERCEPT Blood System for plasma. The INTERCEPT Blood System for plasma is intended to be used for the ex vivo preparation of pathogen-reduced, whole blood derived or apheresis plasma in order to reduce the risk of transfusion-transmitted infection (TTI).
CERS: 6.09 (+0.12)

Cerus reports 1Q loss
Automated Insights - Tue May 03, 3:37PM CDT
CONCORD, Calif. (AP) _ Cerus Corp. (CERS) on Tuesday reported a loss of $16.9 million in its first quarter.
CERS: 6.09 (+0.12)

Cerus Corporation Reports First Quarter 2016 Results
BusinessWire - Tue May 03, 3:01PM CDT
Cerus Corporation (NASDAQ:CERS) today announced financial results for the first quarter ended March 31, 2016.
CERS: 6.09 (+0.12)

Cerus Announces that the Walter Reed National Military Medical Center Has Entered Into Routine Use of the INTERCEPT Blood System
BusinessWire - Tue May 03, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS), a biomedical products company focused in the field of blood transfusion safety, announced today that the Walter Reed National Military Medical Center (Walter Reed), a component of the Armed Services Blood Program, has begun routine use of the INTERCEPT Blood System for apheresis platelets. Walter Reed transfuses approximately 1,000 apheresis platelet units annually.
CERS: 6.09 (+0.12)

Cerus to Release First Quarter 2016 Results on May 3, 2016
BusinessWire - Tue Apr 19, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) announced today that its first quarter results will be released on Tuesday, May 3, 2016, after the close of the stock market. The company will host a conference call and webcast at 4:15 PM ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook.
CERS: 6.09 (+0.12)

The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution
Sean Williams, The Motley Fool - Motley Fool - Sat Apr 16, 1:18PM CDT
The Aedes aegypti mosquito has become public enemy No. 1. Image source: Centers for Disease Control and Prevention. The Zika virus has been around for decades, but its prevalence has exploded since 2014. The virus itself, which is spread by the...
CERS: 6.09 (+0.12), INO: 10.62 (-0.39), MRK: 56.81 (-0.37), NLNK: 11.29 (-0.39), XON: 25.27 (+0.14), GSK: 40.93 (-1.13), SNY: 39.41 (-1.45)

Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma
BusinessWire - Wed Mar 16, 7:30AM CDT
Cerus Corporation (NASDAQ: CERS), a biomedical products company focused on improving blood transfusion safety, today announced U.S. Food and Drug Administration (FDA) approval of the INTERCEPT Blood System for treatment of platelets suspended in 100% plasma. This extended label claim further enhances compatibility with commonly used platelet collection methods.
CERS: 6.09 (+0.12)

Cerus Announces the Inclusion of Pathogen Reduction Technology in FDA's Revised Guidance Document on Bacterial Safety Standards for Platelets
BusinessWire - Tue Mar 15, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) announced today that the U.S. Food and Drug Administration (FDA) has issued a revised draft guidance document titled "Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion; Draft Guidance for Industry." The document is intended to provide blood centers with recommendations for controlling the risk of bacterial contamination of platelets, and pathogen reduction technology is included as a recommended method to reduce the risk of transfusion-transmitted sepsis.
CERS: 6.09 (+0.12)

Covered Call Alerts For Kinder Morgan, Himax Technologies Inc, US Steel, Yahoo! and CERUS Corporation Released By InvestorsObserver
PR Newswire - Thu Mar 10, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for KMI, HIMX, X, YHOO and CERS.
CERS: 6.09 (+0.12), KMI: 17.51 (-0.57), YHOO: 36.83 (-0.52), HIMX: 9.37 (-0.41), X: 17.27 (-0.17)

Blood Centers of America Selects Cerus as its Supply Partner for Pathogen Reduction Technology
BusinessWire - Wed Mar 09, 7:00AM CST
Cerus Corporation (NASDAQ: CERS) and Blood Centers of America (BCA) announced today that they have entered into an agreement with Cerus as a BCA preferred supplier.
CERS: 6.09 (+0.12)

Cerus Corporation Reports Fourth Quarter and Year End 2015 Results
BusinessWire - Tue Mar 08, 3:01PM CST
Cerus Corporation (NASDAQ:CERS) today announced financial results for the fourth quarter and year ended December 31, 2015.
CERS: 6.09 (+0.12)

Cerus Enters Into Agreement With Banco de Sangre de Servicios Mutuos for the Use of INTERCEPT Platelets and Plasma in Puerto Rico to Sustain Blood Supply During Zika Epidemic
BusinessWire - Thu Mar 03, 7:30AM CST
Cerus Corporation (NASDAQ: CERS), a biomedical products company focused on improving blood transfusion safety, today announced that Banco de Sangre de Servicios Mutuos in Puerto Rico has signed a purchase agreement for the INTERCEPT Blood System for platelets and plasma to help protect the local blood supply during the Zika outbreak.
CERS: 6.09 (+0.12)

Covered Call Alerts For Bank of America, CERUS Corporation, Seadrill, Johnson & Johnson and Facebook Released By InvestorsObserver
PR Newswire - Wed Feb 10, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for BAC, CERS, SDRL, JNJ and FB.
CERS: 6.09 (+0.12), JNJ: 117.01 (+0.01), FB: 116.62 (-1.94), BAC: 13.83 (-0.36), SDRL: 3.30 (-0.08)

Cerus Enters Multi-Year Agreement with the American Red Cross for the Use of INTERCEPT Platelets and Plasma
BusinessWire - Tue Feb 09, 7:30AM CST
Cerus Corporation (NASDAQ:CERS) announced today that the American Red Cross has signed a multi-year purchase agreement for the INTERCEPT Blood System for platelets and plasma, which inactivates a broad spectrum of viruses, gram-positive and gram-negative bacteria, spirochetes, parasites and leukocytes and is intended to reduce the risk of transfusion-transmitted infection (TTI) in platelet and plasma components.
CERS: 6.09 (+0.12)

AABB Authorizes Use of the INTERCEPT Blood System for Platelets to Reduce the Risk of Transfusion-Associated Graft Versus Host Disease
BusinessWire - Thu Jan 14, 7:30AM CST
Cerus Corporation (NASDAQ:CERS) announced today that AABB has granted the first requests of U.S. blood centers and hospitals to use INTERCEPT pathogen reduction in place of irradiation to satisfy AABB's requirement to reduce the risk of transfusion-associated graft versus host disease (TA-GVHD).
CERS: 6.09 (+0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RAI's TrustX Lab Unveils AI Assurance Framework

Pushing the Envelope on AI Control Alright, AI wonks, the Responsible AI Institute just introduced a new sheriff in town. It's called the TrustX Assurance Lab, and it was rolled out during RAISE 2026. We're talking about an independent setup designed to answer whether autonomous AI can stay within its limits. Who's involved? A lot of brainpower from member organizations...

Navigating Car Wreck Chaos for Legal Protection

Clarity Amid Chaos: Handling a Crash in Abilene Let me tell you, if your day starts with a car wreck, every second post-crash counts more than you think. Attorney Chaile Allen out of Abilene's laying down the law on how to protect yourself—because that wreck scene ain't just about bent fenders and bruised egos. It's about getting your ducks in a row for any potential...

Bluerock's Split: What November's Trading Change Means

Bluerock's Strategic Move: Untying the Bundle Ah, Bluerock Acquisition Corp. II has thrown a new bone to the market. Starting November 16, 2026, the firm ain't keeping their Class A ordinary shares and warrants locked in a bundle anymore. This shift comes after they sold 17,250,000 units in their IPO back in September, which also saw underwriters fully clinking their...

Inflatable Wonders Turn Christmas into a Hoot at Lowe's

Inflatables Bringing the Cheer (and Laughs) Well, it's that season again—where decorations either have us grumbling at the electric bill or chuckling at the lawn art. Lowe's has teamed up with Gemmy to serve a heaping platter of holiday giggles this year. They've rolled out a quirky lineup of inflatables that go from shivering Highland cows to dinosaurs and elves....

Sound Credit Union, WTA Team Up for Trail Support

Heading Into the Great Outdoors with Every Swipe You ever feel like your money's going nowhere useful? Well, folks in Washington are about to flip the script thanks to Sound Credit Union and the Washington Trails Association (WTA). They've cooked up a slick new money move—a co-branded debit and credit card program—where every swipe backs the state's beloved trails. A...

China-Kenya Trade: Avocado Diplomacy in Action

Avocado: A Trade Symbol with a Pit of Potential Who'd have thought a simple avocado could become such a heavyweight in the international trade arena? But here we are, with Kenyan avocados making a splash on the grand stage at the ninth China International Import Expo in Shanghai. Thanks to zero-tariff treatment, Kenya's prized green exports are rolling into China easier...

Sands China Fosters Cultural Ties with Macau Concert

Macao's Wind Music Legacy Hits a High Note Who would've thought—a gathering of 550 musicians from Macao SAR and France could ignite such a dynamic cross-cultural exchange? Celebrating three decades of musical milestones, the Macau Band Directors Association (MBDA) didn't just throw any old concert but a spectacle that took international collaboration to an upscale...

Yeastar 2026 Summit: AI, Growth, and Global Vision

Reflecting on Two Decades of Innovation Yeastar's 20th anniversary summit in Xiamen was no ordinary gathering. It wasn't just about handshakes and business cards. Nope, it was a celebration intertwined with a deeper vision of growth and influence in the UCaaS space that Yeastar has carved out for itself over the years. Here's a company that's been plotting its course for...

Fake Profiles Dominate Daters' Trust Issues Today

Trust Erosion in the Digital Dating Arena When it comes to modern dating, we're not talking hearts and flowers anymore; it's more like an elaborate game of detective work. A recent survey from Stud or Dud highlights the harsh reality that blind trust in digital dating profiles is about as outdated as sending a singing telegram. Almost half of the respondents pinned fake...

Angels on Call: Leading Dementia Care Recognition

A Milestone in Dementia Care Excellence Angels on Call Homecare has done what no other U.S. homecare provider seems to have managed—nab recognition from the Alzheimer's Association Curriculum Review while also holding the Purple Flag accreditation. That's a combo meal of accolades in the world of dementia care, and it speaks volumes about their commitment to top-notch...